• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020 - Product Image

Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020

  • Published: December 2013
  • Region: Global
  • 135 Pages
  • Allied Analytics LLP
Flow cytometry market was valued $3000 million in 2012, and is expected to reach a value of $6530 million by 2020, experiencing a CAGR of 30.9%.

FEATURED COMPANIES

  • Amnis Corporation
  • Beckman Coulter
  • Becton
  • Dickinson & Co.
  • Ebioscience Inc.
  • Inc.
  • MORE

Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches.

The key market players profiled in this report are BD Biosciences, Beckman Coulter, Merck Millipore, Amnis Corporation, Life Technologies Corporation, Luminex Corporation, Morphosys AG, eBiosciences Inc., Partec Gmbh and Advanced Analytical Technologies, Inc.

KEY BENEFITS

- The report ranks the factors that are responsible to accelerate the market growth of flow cytometry
- Market is forecasted for period of seven years from 2013 to 2020, with market revenues for 2 historic years - 2011 and 2012
- Identification and analysis of key investment pockets for flow cytometry market READ MORE >

CHAPTER 1 INTRODUCTION
1.1 Objective and Scope of the Report
1.2 Key Deliverables of the Report
1.3 Unique Benefits of the Report
1.4 Key Audiences
1.5 Research Methodology
1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL FLOW CYTOMETRY MARKET OVERVIEW
3.1 Market Definition and Scope
3.1.1 Key applications of Flow cytometry
3.1.2 Application of Flow Cytometry in Gender Selection
3.1.3 Flow cytometry in Omics Technology
3.1.3.1 Applications of omics technology
3.1.3.1.1 Lung disease identification
3.1.3.1.2 Quantifying Abnormalities
3.1.3.1.3 Genetic Trait Diagnosis
3.1.3.1.4 Pharmacogenomics
3.1.4 Flow Cytometry in Immunophenotyping
3.1.4.1 Immunophenotyping in hematology applications
3.1.4.1.1 Erythrocyte analysis
3.1.4.1.2 Leukocyte Analysis
3.1.4.1.3 Platelet analysis
3.1.5 Flow cytometry in blood bank
3.1.6 Optimization of Flow Cytometry by Information Technology
3.1.7 Use Of Flow Cytometry In Resource-Poor Regions
3.2 Top factors impacting Flow cytometry Market
3.3 Top three winning strategies in the flow cytometry market
3.3.1 Product Launch
3.3.2 Agreement and Collaboration
3.3.3 Acquisition
3.4 Top investment pockets in flow cytometry market
3.4.1 Flow cytometry market- by clinical application
3.4.2 Flow cytometry market- by Research application
3.4.3 Flow cytometry market- by End users
3.5 Porter’s Five Forces Analysis
3.5.1 Intense Competition DecliningSupplier’s Power
3.5.2 Wide Range of Product Availability Enhances Buyer’s Power
3.5.3 Strategies to Be in Place to Combat Competition
3.5.4 High Investment Restricting Low Investment New Comers
3.5.5 Pricing Issues Impacting Adoption Rates
3.6 Reimbursement Scenario
3.7 Regulatory Issues
3.7.1 Challenges- in FDA Clearance
3.7.2 Impact of ASR Rule
3.7.3 Validation Challenges- Cell-Based
3.7.4 Validation Requirements (CLIA, CAP)
3.7.5 LDT Guidelines on Cell-based Fluorescence
3.7.6 Change in Regulations
3.8 Case studies
3.8.1 Case study 1: Expansion of the number of antibody conjugates
3.8.2 Case study 2: Recognition of target antibodies conjugates, Anti-human CD3: FITC.
3.8.3 Case study 3:To prove precursor B acute lymphoblastic leukemia has unusual transformation
3.8.4 Case study 4: To develop software that can run faster than the current flow cytometer software
3.8.5 Case study 5: To validate the mechanism of a candidate biologic drug
3.9 Market Dynamics
3.9.1 Drivers
3.9.1.1 Technological advancements
3.9.1.2 Clinical and research fields
3.9.1.3 Increase in scope of Applications areas
3.9.1.4 Investment in R&D
3.9.1.5 Increase in number of patients
3.9.2 RESTRAINTS
3.9.2.1 Instrument costs
3.9.2.2 Need of awareness
3.9.2.3 Need of trained personnel
3.9.3 OPPORTUNITIES
3.9.3.1 In clinical approach
3.9.3.2 Research approach

CHAPTER 4 FLOW CYTOMETRY MARKET BY PRODUCT
4.1 Global flow cytometry market, by product type, 2012-2020, $million
4.1.1 Global flow cytometry Product market, by geography, 2012-2020, $million
4.2 Instruments
4.2.1 Global flow cytometry Product market ,by instruments, 2012-2020,$million
4.2.2 Global flow cytometry-instruments market, by geography, 2012-2020, $million
4.2.3 Key Market Drivers
4.2.3.1 Popularity of bench top flow cytometers
4.2.3.2 Technological trends
4.2.4 Platforms
4.2.4.1 Types of platforms
4.2.4.1.1 Single-Platform Approach
4.2.4.1.1.1 TYPES OF SINGLE PLATFORM
4.2.4.2 Global flow cytometry Product market, by platform, 2012-2020,$million
4.2.4.3 Global flow cytometry platform market, by geography, 2012-2020, $million
4.2.4.4 Sorters
4.2.4.4.1 Types of Sorters
4.2.4.5 Analysers
4.2.5 Replaceable Components
4.2.5.1 Drivers of Replaceable Components Market
4.2.5.2 Global flow cytometry replaceable components market, by types, 2012-2020, $million
4.2.5.3 Global flow cytometry replaceable components market, by geography, 2012-2020, $million
4.2.5.4 Filters
4.2.5.4.1 Types of filters
4.2.5.4.2 Global flow cytometry filters market, by geography, 2012-2020, $million
4.2.5.5 Lasers
4.2.5.5.1 Global flow cytometry lasers market, by geography, 2012-2020, $million
4.2.5.6 Detectors
4.2.5.6.1 Global flow cytometry detectors market, by geography, 2012-2020, $million
4.2.5.7 Others
4.2.5.7.1 Global flow cytometry other components market, by geography, 2012-2020, $million
4.2.6 Accessories
4.2.6.1 Global flow cytometry Accessories market, by geography, 2012-2020, $million
4.3 Reagents and Consumables
4.3.1 Drivers of Reagents and consumables market
4.3.2 Global flow cytometry reagents and consumables market, by type, 2012-2020, $million
4.3.3 Global flow cytometry reagents and consumables market, by geography, 2012-2020, $million
4.3.4 Antibodies
4.3.4.1 Global flow cytometry antibodies market, by geography, 2012-2020, $million
4.3.5 Dyes
4.3.5.1 Global flow cytometry dyes market, by geography, 2012-2020, $million
4.3.6 Beads
4.3.6.1 Global flow cytometry beads market, by geography, 2012-2020, $million
4.3.7 Others
4.3.7.1 Reagent kits
4.3.7.2 Beads
4.3.7.3 Solutions
4.3.7.4 Buffers
4.3.7.5 Global flow cytometry other reagents and consumables market, by geography, 2012-2020, $million
4.4 Software
4.4.1 Global flow cytometry market, by software, 2012-2020, $million
4.4.2 Global flow cytometry- software market, by geography, 2012-2020, $million
4.4.3 With-System Software
4.4.3.1 Global flow cytometry with system market, by geography, 2012-2020, $million
4.4.4 Third Party Software
4.4.4.1 Global flow cytometry- third party market, by geography, 2012-2020, $million
4.5 Services
4.5.1 Global flow cytometry services market, by geography, 2012-2020, $million

CHAPTER 5 FLOW CYTOMETRY MARKET BY TECHNOLOGY
5.1 Global flow cytometry market, by technology, 2012-2020, $million
5.2 Global flow cytometry- technology market, by geography, 2012-2020, $million
5.3 Bead-Based Flow cytometry
5.3.1 Drivers of Bead Based Flow Cytometry Market
5.3.1.1 Application in the field of genomics
5.3.1.2 Application in the field of proteomics
5.3.1.3 High competitive edge
5.3.2 Global flow cytometry bead based market, by geography, 2012-2020, $million
5.4 Cell Based Flow Cytometers
5.4.1 Global flow cytometry cell based market, by geography, 2012-2020, $million

CHAPTER 6 FLOW CYTOMETRY MARKET BY APPLICATION
6.1 Drivers of the Flow Cytometry Application Market
6.1.1 Research funds
6.1.2 Need for management in disease control
6.1.3 Increase in flow cytometry end users
6.2 Restraints of the flow cytometry application market
6.3 Global flow cytometry market, by applications, 2012-2020, $million
6.4 Global flow cytometry-application market , by geography, 2012-2020, $million
6.5 Research Applications
6.5.1 Global flow cytometry market, by research applications, 2012-2020, $million
6.5.2 Global flow cytometry-research application market, by geography, 2012-2020, $million
6.5.3 Cell Cycle Analysis and Cell Proliferation
6.5.3.1 Global flow cytometry Cell cycle analysis and Cell proliferation market, by geography, 2012-2020, $million
6.5.4 Apoptosis
6.5.4.1 Drivers of Apoptosis market
6.5.4.2 Global flow cytometry Apoptosis market, by geography, 2012-2020, $million
6.5.5 Cell Sorting
6.5.5.1 Global flow cytometry Cell sorting market, by geography, 2012-2020, $million
6.5.6 Transfection and Cell Viability
6.5.6.1 Global flow cytometry Transfection and Cell viability market, by geography, 2012-2020, $million
6.5.7 Others
6.5.7.1 Global flow cytometry other research application market, by geography, 2012-2020, $million
6.6 Clinical Applications
6.6.1 Global flow cytometry market, by clinical applications, 2012-2020, $million
6.6.2 Global flow cytometry clinical application market, by geography, 2012-2020, $million
6.6.3 Organ Transplantation
6.6.3.1 Drivers of Organ transplantation market
6.6.3.2 Global flow cytometry organ transplant market, by geography, 2012-2020, $million
6.6.4 Hematology Hematological Malignancies
6.6.4.1 Global flow cytometry Hematology hematological malignancies market, by geography, 2012-2020, $million
6.6.4.2 Myeloma
6.6.4.3 Lymphomas
6.6.4.4 Leukemia
6.6.5 Cancer and Solid Tumour
6.6.5.1 Drivers of Cancer and solid tumor market
6.6.5.2 Restraints of Cancer and solid tumor market
6.6.5.3 Global flow cytometry Cancer and solid tumor market, by geography, 2012-2020, $million
6.6.6 Immunodeficiency Disease-HIV Infection
6.6.6.1 Key facts about HIV
6.6.6.2 Drivers of HIV market
6.6.6.3 Restraints of HIV market
6.6.6.4 Global flow cytometry Immunodeficiency disease-HIV infectionmarket, by geography, 2012-2020, $million
6.6.7 Others
6.6.7.1 Global flow cytometry other clinical application market, by geography, 2012-2020, $million

CHAPTER 7 FLOW CYTOMETRY MARKET BY END USER
7.1 Global flow cytometry market, by end user, 2012-2020, $million
7.2 Global flow cytometry end user market, by geography, 2012-2020, $million
7.3 Commercial Organizations
7.3.1 Global flow cytometry commercial market, by geography, 2012-2020, $million
7.4 Medical Schools and Clinical Testing Labs
7.4.1 Global flow cytometry medical schools and clinical testing labs market, by geography, 2012-2020, $million
7.5 Hospitals
7.5.1 Global flow cytometry hospitals market, by geography, 2012-2020, $million
7.6 Academics
7.6.1 Global flow cytometry Academics market, by geography, 2012-2020, $million
7.7 Others
7.7.1 Global flow cytometry other end user market, by geography, 2012-2020, $million

CHAPTER 8 FLOW CYTOMETRY MARKET BY GEOGRAPHY
8.1 North America
8.1.1 Drivers of the North American Market
8.1.2 North American flow cytometry market, 2012-2020, $million
8.2 Europe
8.2.1 Drivers of the European market
8.2.2 European flow cytometry market, 2012-2020, $million
8.3 Asia Pacific and RoW
8.3.1 Asia and RoW flow cytometry market, 2012-2020, $million

CHAPTER 9 COMPANY PROFILES
9.1 Advanced Analytical Technologies, Inc (AATI)
9.1.1 Company Overview
9.1.2 Company Snapshot
9.1.3 Strategies and Development
9.1.4 Swot Analysis of Advanced AnalyticalTechnologies
9.2 Merck Millipore
9.2.1 Company Overview
9.2.2 Company Snapshot
9.2.3 Business Performance
9.2.4 Strategies and Development
9.2.4.1 Primary strategies: Agreement
9.2.4.2 Other strategies
9.2.5 SwotAnalysis of Merck Millipore
9.3 Life Technologies Corporation
9.3.1 Company Overview
9.3.2 Company Snapshot
9.3.3 Business Performance
9.3.4 Strategies and Development
9.3.4.1 Primary Strategies: Agreement
9.3.4.2 Secondary Strategies: Launch and Acquisition
9.3.5 SwotAnalysis of Life Technologies Corporation.
9.4 Beckman Coulter, Inc.
9.4.1 Company overview
9.4.2 Company Snapshot
9.4.3 Strategies and Development
9.4.3.1 Primary strategies: product Launch
9.4.3.2 Secondary strategies: Agreement & acquisition
9.4.4 Swot Analysis OF Beckman Coulter, Inc.
9.5 Becton, Dickinson & Co.
9.5.1 Company Overview
9.5.2 Snapshot of Becton, Dickinson & CO.
9.5.3 Business Performance
9.5.4 Strategies and Development
9.5.4.1 Primary strategies: Launch
9.5.4.2 Other strategies
9.5.5 SWOT analysis of Becton, Dickinson & Co
9.6 Luminex Corporation
9.6.1 Company Overview
9.6.2 Snapshot
9.6.3 Business Performance
9.6.4 Strategies and Development
9.6.4.1 Primary strategies: Agreement
9.6.4.2 Other strategies
9.6.5 Swot Analysis of LUMINEX CORPORATION
9.7 AmnisCorporation
9.7.1 Company Overview
9.7.2 Snapshot
9.7.3 Strategies and Development
9.7.3.1 Primary strategies: Launch
9.7.3.2 Other strategies
9.7.4 SwotAnalysis of AmnisCorporation
9.8 Partec GmbH
9.8.1 Company Overview
9.8.2 Snapshot
9.8.3 Strategies and Development
9.8.4 SwotAnalysis of Partec GmbH
9.9 eBIOSCIENCE, Inc.
9.9.1 Company Overview
9.9.2 Snapshot
9.9.3 Business Performance
9.9.4 Strategies and Development
9.9.4.1 Primary strategies: launch
9.9.4.2 Other strategies
9.9.5 Swot Analysis of eBioscience, Inc.
9.10 MORPHOSYS AG
9.10.1 Company Overview
9.10.2 Snapshot
9.10.3 Business performance
9.10.4 Strategies and Development
9.10.4.1 Primary strategies: Agreement, Launch.
9.10.4.2 Other strategies
9.10.5 Swot Analysis of Morphosys AG

List of Tables

TABLE 1 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 2 GLOBAL FLOW CYTOMETRY MARKET, BY PRODUCT TYPE, 2012-2020, $MILLION
TABLE 3 GLOBAL FLOW CYTOMETRY PRODUCT MARKET BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 4 GLOBAL FLOW CYTOMETRY PRODUCT MARKET BY, INSTRUMENTS, 2012-2020, $MILLION
TABLE 5 GLOBAL FLOW CYTOMETRY-INSTRUMENTS MARKET BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 6 TYPES OF PLATFORM
TABLE 7 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY PLATFORMS, 2012-2020, MILLIONS
TABLE 8 GLOBAL FLOW CYTOMETRY PLATFORM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 9 TYPES OF SORTERS:
TABLE 10 GLOBAL FLOW CYTOMETRY SORTERS MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 11 ANALYZERS BY KEY PLAYERS
TABLE 12 GLOBAL FLOW CYTOMETRY ANALYSERS MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 13 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY REPLACEABLE COMPONENTS MARKET, 2012-2020, $MILLION
TABLE 14 GLOBAL FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 15 TYPES OF FILTERS
TABLE 16 GLOBAL FLOW CYTOMETRY FILTERS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 17 GLOBAL FLOW CYTOMETRY LASERS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 18 TYPES OF DETECTORS
TABLE 19 GLOBAL FLOW CYTOMETRY DETECTORS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 20 GLOBAL FLOW CYTOMETRY OTHER COMPONENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 21 GLOBAL FLOW CYTOMETRY ACCESSORIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 22 GLOBAL FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY TYPE, 2012-2020, $MILLION
TABLE 23 GLOBAL FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 24 GLOBAL FLOW CYTOMETRY ANTIBODIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 25 GLOBAL FLOW CYTOMETRY DYES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 26 GLOBAL FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 27 GLOBAL FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 28 GLOBAL FLOW CYTOMETRY MARKET , BY SOFTWARE, 2012-2020, $MILLION
TABLE 29 GLOBAL FLOW CYTOMETRY- SOFTWARE MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 30 GLOBAL FLOW CYTOMETRY WITH SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 31 GLOBAL FLOW CYTOMETRY- THIRD PARTY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 32 GLOBAL FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 33 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2012-2020, $MILLION
TABLE 34 GLOBAL FLOW CYTOMETRY- TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 35 GLOBAL FLOW CYTOMETRY BEAD BASED MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 36 GLOBAL FLOW CYTOMETRY CELL BASED MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 37 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATIONS, 2012-2020, $MILLION
TABLE 38 GLOBAL FLOW CYTOMETRY-APPLICATION MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 39 GLOBAL FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2012-2020, $MILLION
TABLE 40 GLOBAL FLOW CYTOMETRY-RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 41 GLOBAL FLOW CYTOMETRY CELL CYCLE ANALYSIS AND CELL PROLIFERATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 42 GLOBAL FLOW CYTOMETRY APOPTOSIS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 43 GLOBAL FLOW CYTOMETRY CELL SORTING MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 44 GLOBAL FLOW CYTOMETRY TRANSFECTION AND CELL VIABILITY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 45 GLOBAL FLOW CYTOMETRY OTHER RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 46 GLOBAL FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2012-2020, $MILLION
TABLE 47 GLOBAL FLOW CYTOMETRY CLINICAL APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 48 GLOBAL FLOW CYTOMETRY ORGAN TRANSPLANT MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 49 GLOBAL FLOW CYTOMETRY HEMATOLOGY HEMATOLOGICAL MALIGNANCIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 50 GLOBAL FLOW CYTOMETRY CANCER AND SOLID TUMOR MARKET MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 51 GLOBAL FLOW CYTOMETRY IMMUNODEFICIENCY DISEASE-HIV INFECTION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 52 GLOBAL FLOW CYTOMETRY OTHER CLINICAL APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 53 GLOBAL FLOW CYTOMETRY MARKET, BY END USER, 2012-2020, $MILLION
TABLE 54 GLOBAL FLOW CYTOMETRY END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 55 GLOBAL FLOW CYTOMETRY COMMERCIAL MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 56 GLOBAL FLOW CYTOMETRY MEDICAL SCHOOLS AND CLINICAL TESTING LABS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 57 GLOBAL FLOW CYTOMETRY HOSPITALS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 58 GLOBAL FLOW CYTOMETRY ACADEMICS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 59 GLOBAL FLOW CYTOMETRY OTHER END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 60 NORTH AMERICAN FLOW CYTOMETRY MARKET, 2012-2020, $MILLION
TABLE 61 EUROPEAN FLOW CYTOMETRY MARKET,2012-2020, $MILLION
TABLE 62 ASIA AND ROW FLOW CYTOMETRY MARKET, 2012-2020, $MILLION
TABLE 63 SNAPSHOT OF ADVANCED ANALYTICAL TECHNOLOGIES, INC (AATI)
TABLE 64 SNAPSHOTOF MERCK MILLIPORE,
TABLE 65 SNAPSHOT OF LIFE TECHNOLOGIES CORPORATION
TABLE 66 SNAPSHOT OF BECKMAN COULTER, INC.
TABLE 67 SNAPSHOT OF BECTON DICKINSON
TABLE 68 SNAPSHOT OF LUMINEX CORPORATION
TABLE 69 SNAPSHOT OF AMNISCORPORATION
TABLE 70 SNAPSHOT OF PARTEC GMBH
TABLE 71 SNAPSHOT OF EBIOSCIENCE, INC.
TABLE 72 SNAPSHOT OF MORPHOSYS AG

List of Figures

FIG. 1 FLOW CYTOMETRY MARKET DEFINITION
FIG. 2 TOP FACTORS IMPACTING FLOW CYTOMETRY MARKET(2013-2020)
FIG. 3 TOP THREE WINNING STRATEGIES OF FLOW CYTOMETRY MARKET (2010-2013)
FIG. 4 TOP INVESTMENT MARKETS BY CLINICAL APPLICATION
FIG. 5 TOP INVESTMENT MARKETS BY RESEARCH APPLICATION
FIG. 6 TOP INVESTMENT MARKETS BY END-USERS
FIG. 7 PORTER’S FIVE FORCE ANALYSIS
FIG. 8 TYPES OF PLATFORM
FIG. 9 NUMBER OF TRANSPLANTS PERFORMED IN THE UNITED STATES (2012)
FIG. 10 ESTIMATED NEW CASES OF LEUKEMIA, LYMPHOMA, MYELOMA (2013)
FIG. 11 ESTIMATED NEW CASES AS PER TYPES OF LEUKEMIA (2013)
FIG. 12 ESTIMATED NEW CASES AND DEATHS IN U.S. (2012)
FIG. 13 TOP TEN COUNTRIES IN CANCER POPULATION (PER 1, 00,000 PEOPLE) 2011
FIG. 14 POPULATION LIVING WITH HIV/AIDS (TOP TEN COUNTRIES) 2012
FIG. 15 ESTIMATED NUMBER OF NEW CANCER CASES AND DEATHS, BY SITES U.S (2013)
FIG. 16 SWOT ANALYSIS OF ADVANCED ANALYTICAL TECHNOLOGIES, INC (AATI)
FIG. 17 FINANCIAL REVENUES OF MERCK MILLIPORE SALES BY BUSINESS UNIT (2012)
FIG. 18 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHIC AREAS (2012)
FIG. 19 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 20 FINANCIAL REVENUES BY END MARKETS (2012)
FIG. 21 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 22 SWOT ANALYSIS OF LIFE TECHNOLOGIES CORPORATION
FIG. 23 SWOT ANALYSIS OF BECKMAN COULTER, INC
FIG. 24 FINANCIAL REVENUES OF BECTON, DICKINSON & CO. BY GEOGRAPHIC AREAS (2012)
FIG. 25 FINANCIAL REVENUES OF BECTON, DICKINSON & CO. BY BUSINESS UNITS (2012)
FIG. 26 SWOT ANALYSIS OF BECTON, DICKINSON & CO
FIG. 27 REVENUE BY SALES TO CUSTOMERS (2012)
FIG. 28 SWOT ANALYSIS OF LUMINEX CORPORATION
FIG. 29 SWOT ANALYSIS OF AMNIS CORPORATION
FIG. 30 SWOT ANALYSIS OF PARTEC GMBH
FIG. 31 SWOT ANALYSIS OF EBIOSCIENCE, INC
FIG. 32 FINANCIAL REVENUES OF MORPHOSYS AG BY BUSINESS UNITS (2012)
FIG. 33 FINANCIAL REVENUES OF MORPHOSYS AG BY GEOGRAPHIC AREAS (2012)
FIG. 34 SWOT ANALYSIS OF MORPHOSYS AG

Flow Cytometry Market will Reach $6.5 Billion Globally by 2020 with Increasing Precision. As per the study, the flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9%. Increasing needs to enhance precisions and produce faster results as well as need for compact devices are compelling the clinical and diagnostic organization to adopt innovative technologies. Though popularity has been gained in the application field of life science industry, the cost of the instrument is impeding the growth. Due to this, many researchers are still reluctant in adopting this technology in their research work. Moreover, advancing technologies that has brought complex instrumentation requires highly skilled personals to operate these instruments. ""Flow cytometry market is in developing phase. Enhancing precision in results and presence of numerous flow cytometry techniques such as multicolor and multi-parameter flow cytometry has acted as a strong foothold, assisting the market growth in majority of the developed economies and foresees high potential in the emerging economies such as Asia Pacific and Africa.

These economies have high demand for better health care techniques at an affordable cost. Increasing aged population who need better healthcare, increase in chronic disease and need for better diagnosis and treatment are few driving factors that are impacting the flow cytometry market"" state AMR analysts Debbie Shields and Rohini Patil.

Immunotyping and signal transduction, for example, have been playing a significant role in medical diagnostics. However, conventional technologies used, have limited the accuracy and impacted the result deliverance time of the diagnosis performed. Improving therapeutic scenario is equally attracting focus on early diagnostic tools. Currently, many cancer types have various treatment options; however, this depends on the time of diagnosis and the stage of the cancer. Flow cytometry has been one of the most prevalent technologies which offer solutions for most of the problems discussed above. Key factors restraining the market include high instrument costs and size, lack of awareness among probable users and need for trained personnel.

Most of the users are not aware of the advanced development in the flow cytometry technology and believe that the instruments are space consuming, complex in use and are of high cost, thus affecting the market growth. The global market for flow cytometry is divided into segments such as products, technology, end users, and applications. Instruments market accounts for the largest share of revenue in the flow cytometry market at present and is expected to remain as the highest revenue generator in 2020. Increase in modularity, accessibility, incorporation of imaging capabilities, availability of wavelengths and targets and size reduction are few of the significant trends in the market assisting in adoption of the instruments by the end users.

On the other hand, reagents market is expected to experience the highest growth rate of CAGR 12% during the analysis period. Primary reason escalating this segment is availability of several types of reagents that find diverse usability depending on specific applications like diagnostics, drug discovery, etc.Two technologies are implemented in flow cytometry based research and diagnosis, namely cell based and bead based technologies. In the present scenario as well as throughout the analysis period, cell based technique is leading the market in terms of revenue generation. However, bead based technique is expected to beat this technology in terms of adoption rate by 2020.

North America accounted for the largest share of revenue i.e. 43.5% of the overall Global flow cytometry market at $1.2 billion in 2011. The region is further expected to attain a market size of $2.8 billion by 2020 growing at a CAGR of 10.1%. The company profile in this includes: Advanced analytical Technologies, Inc., Merck Millipore, Becton, Dickinson & co, Beckman Coulter, eBioscience, Partech, Life technologies corp., Luminex Corp, Amnis Corp., Morphosys AG. The primary strategy employed by key players of the market is products launch which is due to demand for newer, faster, and high through put machines that deliver better results.

- Advanced Analytical Technologies Inc (AATI)
- Amnis Corporation
- Beckman Coulter
- Becton
- Dickinson & Co.
- Ebioscience Inc.
- Inc.
- Life Technologies Corporation
- Luminex Corporation
- Merck Millipore
- Morphosys AG
- Partec GmbH

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos